首页> 外文期刊>American Journal of Physiology >Monocrotaline pyrrole-induced endothelial cell megalocytosis involves a Golgi blockade mechanism.
【24h】

Monocrotaline pyrrole-induced endothelial cell megalocytosis involves a Golgi blockade mechanism.

机译:Monocrotaline吡咯诱导的内皮细胞巨细胞增多涉及高尔基体阻断机制。

获取原文
获取原文并翻译 | 示例
           

摘要

Pyrrolizidine alkaloids initiate disease in the lung (pulmonary hypertension), liver (veno-occlusive disease and cirrhosis), and kidneys (afferent arteriolar block and mesangiolysis) by inducing a megalocytotic phenotype in target endothelial and parenchymal cells. A "hit-and-run" type of exposure to the bioactive pyrrolizidine results, within 2-3 days, in enlarged cells with large nuclei and enlarged Golgi and endoplasmic reticulum, while the cells remain in G2/M block. In the present study, we recapitulated monocrotaline pyrrole (MCTP)-induced megalocytosis in cultures of bovine pulmonary arterial endothelial cells (PAEC), human Hep3B hepatocytes, human type II-like alveolar epithelial cells (A549), and human pulmonary arterial smooth muscle cells (PASMC) and investigated the subcellular mechanism involved. There was an inverse relationship between reduction in caveolin (Cav)-1 levels and stimulation of promitogenic STAT3 and ERK1/2 cell signaling. In megalocytotic PAEC, the Golgi scaffolding proteinGM130 was shifted from membranes with heavy density to those with a lighter density. This lighter Golgi fraction was enriched for hypo-oligomeric Cav-1, indicating dysfunctional trafficking of cargo. Immunofluorescence imaging studies confirmed the trapping of Cav-1 in a GM130-positive Golgi compartment. There was an increase in Ser25 phosphorylation of GM130 (typically a prelude to Golgi fragmentation and mitosis) and increased association between pGM130, cdc2 kinase, and Cav-1. Nevertheless, megalocytotic MCTP-treated cells showed reduced entry into mitosis upon stimulation with 2-methoxyestradiol (2-ME), reduced 2-ME-induced Golgi fragmentation, and a slowing of Golgi reassembly after nocodazole-induced fragmentation. These data suggest that a disruption of the trafficking and mitosis sensor functions of the Golgi may represent the subcellular mechanism leading to MCTP-induced megalocytosis ("the Golgi blockade hypothesis").
机译:吡咯嗪核生物碱通过在靶内皮细胞和实质细胞中诱导巨噬细胞表型,从而引发肺部疾病(肺动脉高压),肝脏(静脉阻塞性疾病和肝硬化)和肾脏疾病(轻度小动脉阻塞和血管舒张)。在2到3天之内,“活着”暴露于生物活性吡咯烷啶的结果是,细胞增大且细胞核较大,高尔基体和内质网也增大,而细胞仍处于G2 / M阻滞状态。在本研究中,我们概述了牛气瓶吡咯(MCTP)诱导的牛肺动脉内皮细胞(PAEC),人Hep3B肝细胞,人II型样肺泡上皮细胞(A549)和人肺动脉平滑肌细胞培养物中的巨噬细胞增多(PASMC)并研究了涉及的亚细胞机制。降低洞穴蛋白(Cav)-1水平与刺激促有丝分裂的STAT3和ERK1 / 2细胞信号转导之间存在反比关系。在巨细胞PAEC中,高尔基体支架蛋白GM130从高密度的膜转移到了较轻的膜。该较轻的高尔基级分富含低聚Cav-1,表明货物运输不正常。免疫荧光成像研究证实,Cav-1被捕获在GM130阳性高尔基体中。 GM130的Ser25磷酸化增加(通常是高尔基体分裂和有丝分裂的前奏),pGM130,cdc2激酶和Cav-1之间的关联增加。然而,巨细胞吞噬MCTP处理的细胞显示2-甲氧基雌二醇(2-ME)刺激后进入有丝分裂的程度降低,2-ME诱导的高尔基体碎裂减少,诺考达唑诱导的碎片后高尔基体重组减慢。这些数据表明,高尔基体的运输和有丝分裂传感器功能的破坏可能代表了导致MCTP诱导的巨细胞增多的亚细胞机制(“高尔基体阻断假说”)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号